LGSOC has a stable genome and low mutational load (median mutational burden <1 mutation/Mb), very different from high-grade serous ovarian cancer, which is characterized by high genomic instability, with nearly universal TP53 mutation. The gene discussed is TP53; the disease is ovarian serous adenocarcinoma.